Cybin Inc
CYBN6.070USD
+0.120+2.02%
收盤 11/06, 16:00（美東）報價延遲15分鐘
139.81M總市值
虧損本益比TTM
關於 Cybin Inc 公司
Cybin Inc. 是一家總部位於加拿大的臨牀階段生物製藥公司。該公司開發基於迷幻藥的療法，以滿足患有精神疾病的人對治療方案的未滿足需求。其 N,N-二甲基色胺 (DMT) 和 dDMT 項目創建了對這些迷幻分子進行系統研究的數據集。該公司正在開發 CYB003（一種用於治療重度抑鬱症的專有氘代裸蓋菇素類似物）和 CYB004（一種用於治療廣泛性焦慮症的專有氘代 dDMT 分子），並擁有一系列基於迷幻藥的在研化合物。CYB003 進入第三階段，CYB004 進入第二階段。它在迷幻藥開發領域擁有知識產權組合，已獲得 30 多項專利，還有 160 項專利正在申請中。該公司在加拿大、美國、英國、荷蘭和愛爾蘭開展業務。
Cybin Inc簡介
公司代碼CYBN
公司名稱Cybin Inc
上市日期Jan 05, 2018
CEOMr. Eric How-Lun So
員工數量50
證券類型Ordinary Share
年結日Jan 05
公司地址100 King Street West
城市TORONTO
上市交易所Aequitas NEO-L
國家Canada
郵編M5X 1C9
電話19087648385
網址https://www.cybin.com
公司代碼CYBN
上市日期Jan 05, 2018
CEOMr. Eric How-Lun So
Cybin Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Alex Nivorozhkin
Mr. Alex Nivorozhkin
Chief Scientific Officer
Chief Scientific Officer
5.25M
+5.65%
Mr. Gabriel Fahel
Mr. Gabriel Fahel
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
405.35K
+0.54%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Executive Chairman of the Board, President, Interim Chief Executive Officer
Executive Chairman of the Board, President, Interim Chief Executive Officer
311.12K
-97.41%
Mr. Paul Glavine
Mr. Paul Glavine
Director, Chief Growth Officer
Director, Chief Growth Officer
299.67K
-97.37%
Ms. Theresa Firestone
Ms. Theresa Firestone
Lead Independent Director
Lead Independent Director
1.06K
-97.37%
Mr. Grant B. Froese
Mr. Grant B. Froese
Independent Director
Independent Director
--
--
Mr. Greg Cavers
Mr. Greg Cavers
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Lawson
Mr. Mark Lawson
Independent Director
Independent Director
--
--
Mr. Aaron Bartlone
Mr. Aaron Bartlone
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Eric Hoskins
Dr. Eric Hoskins
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Alex Nivorozhkin
Mr. Alex Nivorozhkin
Chief Scientific Officer
Chief Scientific Officer
5.25M
+5.65%
Mr. Gabriel Fahel
Mr. Gabriel Fahel
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
405.35K
+0.54%
Mr. Eric How-Lun So
Mr. Eric How-Lun So
Executive Chairman of the Board, President, Interim Chief Executive Officer
Executive Chairman of the Board, President, Interim Chief Executive Officer
311.12K
-97.41%
Mr. Paul Glavine
Mr. Paul Glavine
Director, Chief Growth Officer
Director, Chief Growth Officer
299.67K
-97.37%
Ms. Theresa Firestone
Ms. Theresa Firestone
Lead Independent Director
Lead Independent Director
1.06K
-97.37%
Mr. Grant B. Froese
Mr. Grant B. Froese
Independent Director
Independent Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 10月25日 週六
更新時間: 10月25日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Nivorozhkin (Alex)
19.01%
Tang Capital Management, LLC
6.63%
Point72 Asset Management, L.P.
5.82%
Global X Investments Canada Inc.
4.85%
Tziras (George)
4.69%
其他
59.01%
持股股東
持股股東
佔比
Nivorozhkin (Alex)
19.01%
Tang Capital Management, LLC
6.63%
Point72 Asset Management, L.P.
5.82%
Global X Investments Canada Inc.
4.85%
Tziras (George)
4.69%
其他
59.01%
股東類型
持股股東
佔比
Individual Investor
31.63%
Hedge Fund
21.19%
Investment Advisor
6.79%
Investment Advisor/Hedge Fund
5.13%
Private Equity
0.41%
Research Firm
0.32%
Bank and Trust
0.05%
其他
34.47%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
186
9.89M
36.92%
-76.12M
2025Q2
203
58.05M
152.46%
-77.16M
2025Q1
209
57.54M
286.29%
-78.15M
2024Q4
205
59.72M
283.54%
-81.34M
2024Q3
197
62.29M
285.74%
-324.75M
2024Q2
204
344.93M
166.65%
-48.46M
2024Q1
195
368.84M
163.99%
+249.67M
2023Q4
177
108.66M
110.45%
+25.70M
2023Q3
166
58.71M
23.51%
+14.44M
2023Q2
156
50.00M
26.24%
+942.60K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Nivorozhkin (Alex)
5.25M
20.85%
+280.74K
+5.65%
Mar 31, 2024
Tang Capital Management, LLC
1.83M
7.27%
--
--
Jun 30, 2025
Point72 Asset Management, L.P.
1.61M
6.38%
+280.13K
+21.12%
Jun 30, 2025
Global X Investments Canada Inc.
1.34M
5.32%
-213.08K
-13.73%
Feb 29, 2024
Tziras (George)
1.29M
5.14%
--
--
Jul 24, 2024
Deep Track Capital LP
1.53M
6.07%
--
--
Jun 30, 2025
Bartlone (Aaron Frank)
901.07K
4.51%
+200.00K
+28.53%
Jun 28, 2024
Rosalind Advisors, Inc.
810.92K
3.22%
--
--
Jun 30, 2025
Acorn Capital Advisors, LLC
734.39K
2.92%
--
--
Jun 30, 2025
Fahel (Gabriel)
405.35K
1.61%
+2.17K
+0.54%
Sep 02, 2025
查看更多
持股ETF
更新時間: 20 小時前
更新時間: 20 小時前
機構名稱
佔比
AdvisorShares Psychedelics ETF
4.97%
iShares Biotechnology ETF
0.01%
Simplify Propel Opportunities ETF
0%
AdvisorShares Psychedelics ETF
佔比4.97%
iShares Biotechnology ETF
佔比0.01%
Simplify Propel Opportunities ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Aug 28, 2024
Merger
38→1
Aug 28, 2024
Merger
38→1
Aug 28, 2024
Merger
38→1
Aug 28, 2024
Merger
38→1
公告日期
類型
比率
Aug 28, 2024
Merger
38→1
Aug 28, 2024
Merger
38→1
Aug 28, 2024
Merger
38→1
Aug 28, 2024
Merger
38→1
